skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Peter, I'm a pensioner and hold BCE in my RRSP account mainly for the dividend with an average cost of 49.25. Why such a downturn and would you continue to hold for the dividend or is there a chance the dividend could be lowered or cut. I thought this was one of those buy and forget about stocks. Thanks
Read Answer Asked by Nick on April 03, 2024
Q: Thank You for your quick response. In my own little world, I continue to believe that DYA has a great concept. I just can’t understand why the product cannot be designed and manufactured to meet customer/market expectations! At a time when gas and diesel prices are at ‘all time highs’ and the introduction of this product is supposed to reduce fuel consumption to allow companies to save enough in a 12 month period to pay for the purchase…it’s just not registering with me why there’s such a struggle to sell the product! In saying the above, and with so many businesses/investors who could do ‘so much’ with a product like this, do you feel it could possibly be bought or taken over in the coming months? Thank you again.
Read Answer Asked by Stan on April 03, 2024
Q: This stock is up 3.1% YTD and 17.6% 1 Year.

Not a bad performance but certainly underperfoming the general market.

There are a lot of excellent companies on New York and Nasdaq that have a much steeper growth profile than QSR.

If you were to look at the universe of their consumer segment of the market which US company do you feel would have the highest growth potential over the next 3 years. (Other than SBUX)

With thanks


Sheldon
Read Answer Asked by Sheldon on April 03, 2024
Q: Hello 5i,
So, retired, dividend-oriented investor looking to add to Healthcare in Canada for a RRIF. Our primary healthcare holding is a full position in HHL, for the yield. P.A. indicates that we are overweight U.S. and need to increase our Canadian holding while healthcare is underweight.
We were considering CSH.UN, but it seems to be classed as a REIT (real estate is also overweight), so that doesn't seem to be an option. The 2 remaining choices seem to be either SIA or EXE, both seeming somewhat problematic.
Since the latest questions I could find on either SIA or EXE date back to last fall, could you update your analysis on these two equities with a view to whether either would be a suitable investment for us and whether the dividends appear safe for the foreseeable future?
And, finally, are there any other suitable Canadian healthcare options that pay a dividend?
Where there is nothing suitable in Canada, my thought was to return to ABBV and suck up the geographical imbalance. Thoughts?

As always, many thanks for your awesome service!!! It is very much appreciated!
Thanks,
Cheers,
Mike
Read Answer Asked by Mike on April 03, 2024
Q: Please rank these royalty companies in order of preference disregarding the market cap. Thanks.
Read Answer Asked by Marco on April 03, 2024
Q: If you were a gambling man, which Canadian companies (tsx or venture) would you bet get acquired sooner rather than later?
Read Answer Asked by Shweta on April 03, 2024
Q: These 3 new Hamilton covered call etf's seem to my untrained eye to provide a very smart blend of generous income in excess of 10% annually each as advertised plus 70% of the holdings aren't subject to the call writing and thus are able to deliver a substantial portion of potential capital growth. The current portfolios for all three seem well chosen, solid picks. Each of these etf's has over $100 million invested rather quickly and they are likely to continue subscription growth. Newness aside, what's not to like for income plus exposure to a basket of high-grade US healthcare, financials and Cdn and US energy equities? Whatcha think? Thank you.
Read Answer Asked by Ken on April 02, 2024
Q: Was just re-reading the 2022 5i report on FSV and reviewing some recent answers to questions whereby you remain positive on the name. Can you provide a quick update on a few things in the report, like the key risks then versus now, and comment on the current valuation on a forward basis (and anything else new/changed, positive or negative that you think is worth considering before making the decision to buy now). Thanks.
Read Answer Asked by Stephen R. on April 02, 2024